Chemoradiation treatment with or without concurrent tumor-treating fields (TTFields) therapy in newly diagnosed glioblastoma (GBM) patients in China
Concurrent CRT and TTFields therapy emerged safe for newly diagnosed GBM patients. Although no significant survival differences were found between the CA-TTF and A-TTF groups, the potential benefit of concurrent TTFields warrants further investigation through large-scale clinical trials.
Authors
- Wenjia Zhu (ORCID: https://orcid.org/0000-0003-1397-4544)
- Chunxia Ni
- Wanzun Lin (ORCID: https://orcid.org/0000-0003-3973-8849)
- Wenyin Shi (ORCID: https://orcid.org/0000-0002-6336-3912)
- Zhirui Zhou
- Jiabing Liu
- Yang Wang (ORCID: https://orcid.org/0000-0002-0611-3669)
- Shu Chen (ORCID: https://orcid.org/0009-0006-2406-0309)
- Junyan Zhang (ORCID: https://orcid.org/0000-0002-7890-3707)
- Zhiyong Qin (ORCID: https://orcid.org/0000-0002-7434-7985)
- Liping Liang (ORCID: https://orcid.org/0009-0001-5638-5881)
- Lingchao Chen (ORCID: https://orcid.org/0009-0007-6658-9101)
- Xianxin Qiu
Institutions
- Thomas Jefferson University (US)
- Fudan University (CN)
- Fudan University Shanghai Cancer Center (CN)
- Sidney Kimmel Cancer Center (US)
- Shanxi Academy of Medical Sciences (CN)
- Huashan Hospital (CN)
Publication Details
- Journal
- Chinese Neurosurgical Journal
- Published
- 2025-03-07
- DOI
- https://doi.org/10.1186/s41016-025-00391-w
- Citations
- 1
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.63